Found: 26
Select item for more details and to access through your institution.
Anti-erbB-2 antibody trastuzumab in the treatment of HER2-amplified breast cancer.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 5, p. 391, doi. 10.1007/s10637-005-2899-8
- By:
- Publication type:
- Article
Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells.
- Published in:
- Oncogene, 1999, v. 18, n. 44, p. 6050, doi. 10.1038/sj.onc.1202993
- By:
- Publication type:
- Article
Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs.
- Published in:
- Oncogene, 1998, v. 17, n. 17, p. 2235, doi. 10.1038/sj.onc.1202132
- By:
- Publication type:
- Article
Genetic polymorphisms of multiple DNA repair pathways impact age at diagnosis and TP53 mutations in breast cancer.
- Published in:
- Carcinogenesis, 2011, v. 32, n. 9, p. 1354, doi. 10.1093/carcin/bgr117
- By:
- Publication type:
- Article
Single-cell immunoblotting resolves estrogen receptor-α isoforms in breast cancer.
- Published in:
- PLoS ONE, 2021, v. 16, n. 7, p. 1, doi. 10.1371/journal.pone.0254783
- By:
- Publication type:
- Article
Biodistribution and Predictive Value of <sup>18</sup>F-Fluorocyclophosphamide in Mice Bearing Human Breast Cancer Xenografts.
- Published in:
- Journal of Nuclear Medicine, 2007, v. 48, n. 12, p. 2021, doi. 10.2967/jnumed.107.045716
- By:
- Publication type:
- Article
Predicting Chemotherapy Response to Paclitaxel <sup>18</sup> with F-Fluoropaclitaxel and PET.
- Published in:
- Journal of Nuclear Medicine, 2006, v. 47, n. 12, p. 1995
- By:
- Publication type:
- Article
Estimation of Paclitaxel Biodistribution and Uptake in Human-Derived Xenografts In Vivo with <sup>18</sup>F-Fluoropaclitaxel.
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 11, p. 1866
- By:
- Publication type:
- Article
HER-2/neu Gene Amplification and Response to Paclitaxel in Patients With Metastatic Breast Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2004, v. 96, n. 15, p. 1141, doi. 10.1093/jnci/djh198
- By:
- Publication type:
- Article
Rational combinations of trastuzumab with chemotherapeutic drugs used in the treatment of breast cancer.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Results of two open-label, multicenter phase II studies of docetaxel, platinum salts, and trastuzumab in HER2-positive advanced breast cancer.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Electrophoretic cytopathology resolves ERBB2 forms with single-cell resolution.
- Published in:
- NPJ Precision Oncology, 2018, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41698-018-0052-3
- By:
- Publication type:
- Article
Everything Old is Neu Again: Cellular Senescence in HER2-Positive Breast Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 5, p. 1, doi. 10.1093/jnci/djv091
- By:
- Publication type:
- Article
Everything old is neu again: cellular senescence in HER2-positive breast cancer.
- Published in:
- 2015
- By:
- Publication type:
- editorial
Clinical validation of an immunohistochemistry‐based CanAssist‐Breast test for distant recurrence prediction in hormone receptor‐positive breast cancer patients.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 4, p. 1755, doi. 10.1002/cam4.2049
- By:
- Publication type:
- Article
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2007, v. 131, n. 1, p. 18, doi. 10.5858/2007-131-18-asocco
- By:
- Publication type:
- Article
Hydrogel Pore-Size Modulation for Enhanced Single-Cell Western Blotting.
- Published in:
- Advanced Materials, 2016, v. 28, n. 2, p. 327, doi. 10.1002/adma.201503939
- By:
- Publication type:
- Article
Targeted prodrug treatment of HER-2-positive breast tumor cells using trastuzumab and paclitaxel linked by A-Z-CINN<sup>TM</sup> Linker.
- Published in:
- Journal of Experimental Therapeutics & Oncology, 2003, v. 3, n. 1, p. 27, doi. 10.1046/j.1359-4117.2003.01064.x
- By:
- Publication type:
- Article
HER2-Targeted Combinations in Advanced HER2-Positive Breast Cancer.
- Published in:
- Oncology (08909091), 2015, v. 29, n. 11, p. 797
- By:
- Publication type:
- Article
Tumor Biology Trumps Anatomy in Breast Cancer Brain Metastases.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 7, p. 666
- By:
- Publication type:
- Article
The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells.
- Published in:
- Oncogene, 1997, v. 15, n. 5, p. 537, doi. 10.1038/sj.onc.1201222
- By:
- Publication type:
- Article
Usefulness of 3'-[F-18]fluoro-3'-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Real-world Evidence of Diagnostic Testing and Treatment Patterns in US Patients With Breast Cancer With Implications for Treatment Biomarkers From RNA Sequencing Data.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Novel Treatment Advances and Approaches in the Management of HER2-Positive Advanced Breast Cancer: Expert Strategies on the Role of New and Emerging Therapies.
- Published in:
- Journal of Managed Care Medicine, 2022, v. 25, n. 1, p. 9
- By:
- Publication type:
- Article
PF-05280014 (a trastuzumab biosimilar) plus paclitaxel compared with reference trastuzumab plus paclitaxel for HER2-positive metastatic breast cancer: a randomised, double-blind study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Targeted Therapy in Metastatic Breast Cancer: The HER2/neu Oncogene.
- Published in:
- Breast Care, 2010, v. 5, p. 3, doi. 10.1159/000285714
- By:
- Publication type:
- Article